Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

The study found that Temporal Triangular Alopecia often starts in early childhood, mainly affects the left side of the scalp, and has no effective treatment except surgery.

Oral minoxidil effectively increases hair growth in male baldness but can cause side effects like excessive hair growth and swelling.

Oral minoxidil improved male baldness, but had side effects; certain antibiotics effectively treated a rare scalp condition; hair transplants might trigger another scalp condition.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Smoking and drinking can lower vitamin levels and potentially trigger early hair loss, but overall vitamin levels don't seem to affect hair loss duration.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

People with TED often have low B12 levels and might benefit from B12 supplements.

The study found that Frontal Fibrosing Alopecia in North-East India mainly affects middle-aged women and is often associated with lichen planus pigmentosus.

Low-dose naltrexone helps reduce symptoms and slow down lichen planopilaris without side effects.

Allergic scalp reactions can cause temporary hair loss.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

COVID-19 can cause hair loss starting as early as 18 days after infection.

Trichoscopy is not specific for diagnosing telogen effluvium and both telogen effluvium and androgenetic alopecia often occur together.

Hair loss in Telogen effluvium is often chronic, linked to stress, and lacks a confirmed treatment, but topical corticosteroids may be used.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

For sensitive scalp, treatment is personalized and may include specific medications and hydration, while avoiding stress and irritating products.

Hair loss in men (androgenetic alopecia) is significantly linked to decreased scalp sensitivity, but not temperature sensitivity. More research is needed to confirm this. Comparing this hair loss to leprosy is unsupported and stigmatizing.

Hair loss in androgenetic alopecia may be due to ongoing tiny inflammation and tissue changes around hair follicles.

MMP® with minoxidil may improve hair growth in chronic telogen effluvium.

Nutrients can help improve hair growth and thickness caused by pollution.

Dr. SKS hair booster serum effectively treats hair loss caused by COVID-19.

Trichoscopy helps tell apart other hair loss conditions from common hair loss.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

Some children may develop hair loss after having COVID-19.